{"id":510112,"title":"Qualifying notice for Retevmo (298049) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T04:20:05.923000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-retevmo-298049.html","snippet":"Qualifying notice for Retevmo (298049) Pharmaceutical Drugs Directorate Holland Cross, Tower \"B\" 6th Floor, 1600 Scott Street Address Locator #3106B Ottawa ON K1A 0K9 Dossier ID: e233861 Control number: 298049 Eli Lilly Canada Inc [name of employee removed] Director-Global…","rawSnapshotUrl":"/api/snapshots/raw/510112","browseUrl":"https://replay.healtharchive.ca/job-6/20260216042005/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-retevmo-298049.html#ha_snapshot=510112","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}